Just remember, 85% of phase 3 drugs make it to commercialisation so the odds are much better but it’s still not a guarantee if this goes ahead.. Sounds like some are counting their money if this phase 3 gets the green light. There are reasons it’s not 100% after phase 3.
Sharewise Presentation 22/7/24, page-50
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.015(7.50%) |
Mkt cap ! $75.30M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 20.0¢ | $175.5K | 833.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 8334 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |